Of note, apoIV gene expression, which has been associated previously with hepatic steatosis and with increased secretion of larger TG‐enriched apoB‐containing VLDL,31 was increased in P465L livers, independent of the nutritional and pharmacological challenge. The gene discussed is APOB; the disease is fatty liver disease.